Abstract
We synthesized carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives 3a-u and evaluated their anti-cholinesterase activities. In vitro evaluation showed that cyclohexylmethylcarbamate derivative 3u potently and selectively inhibits butyrylcholinesterase.
Copyright 2010 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetylcholinesterase / chemistry
-
Acetylcholinesterase / metabolism
-
Butyrylcholinesterase / chemistry*
-
Butyrylcholinesterase / metabolism
-
Carbamates / chemistry*
-
Cholinesterase Inhibitors / chemical synthesis*
-
Cholinesterase Inhibitors / chemistry
-
Cholinesterase Inhibitors / pharmacology
-
Drug Design
-
Humans
-
Neuroprotective Agents / chemical synthesis*
-
Neuroprotective Agents / chemistry
-
Neuroprotective Agents / pharmacology
-
Physostigmine / analogs & derivatives*
-
Physostigmine / chemical synthesis
-
Physostigmine / chemistry
-
Physostigmine / pharmacology
-
Structure-Activity Relationship
Substances
-
Carbamates
-
Cholinesterase Inhibitors
-
Neuroprotective Agents
-
Physostigmine
-
Acetylcholinesterase
-
Butyrylcholinesterase